Dynamic 18F‐FDG PET / CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer

医学 肺癌 免疫疗法 接收机工作特性 正电子发射断层摄影术 核医学 新辅助治疗 病态的 化疗 肿瘤科
作者
Zhiyong Chen,Rui Fu,Xiaoyue Tan,Li‐Xu Yan,Wen‐Fang Tang,Zhen‐Bin Qiu,Yi‐Fan Qi,Yufa Li,Qingyi Hou,Yi-Long Lung Cancer Wu,Wen‐Zhao Zhong,Ben‐Yuan Jiang
出处
期刊:Thoracic Cancer [Wiley]
卷期号:13 (17): 2524-2531 被引量:24
标识
DOI:10.1111/1759-7714.14562
摘要

Abstract Major pathological response (MPR) is a potential surrogate for overall survival. We determined whether the dynamic changes in 18F‐labeled fluoro‐2‐deoxyglucose positron emission tomography/computed tomography (18F‐FDG PET/CT) were associated with MPR in patients receiving neoadjuvant immunotherapy. Forty‐four patients with stage II–III non‐small cell lung cancer (NSCLC) who received neoadjuvant immunotherapy and radical surgery were enrolled. Moreover, 18F‐FDG PET/CT scans were performed at baseline and within 1 week before surgery to evaluate the disease. All histological sections were reviewed to assess MPR. The detailed clinical features of the patients were analyzed. The reliability of the clinical variables was assessed in differentiating between MPR and non‐MPR using logistic regression. Receiver‐operating characteristic (ROC) curve analysis identified the SUVmax changes threshold most associated with MPR. Most of the patients were pathologically diagnosed with squamous cell carcinoma and received anti‐PD‐1 antibodies plus chemotherapy. The immunotherapy regimens included nivolumab, pembrolizumab, and camrelizumab. MPR was observed in more than half of lesions. Tumors with MPR had a higher decrease in the longest dimension on dynamic PET/CT than those without MPR. Furthermore, the decline in SUVmax was significantly different between MPR and non‐MPR diseases, and MPR lesions had a prominent mean reduction in SUVmax. SUVmax reduction was independently associated with MPR in the multivariate regression. On ROC analysis, the threshold of SUVmax decrease in 60% was associated with MPR. Dynamic changes in SUVmax were associated with MPR. The tumors with MPR showed a greater PET/CT response than those without MPR. A SUVmax decrease of more than 60% is more likely to result in an MPR after receiving neoadjuvant immunotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Celeste完成签到 ,获得积分10
刚刚
kipo完成签到 ,获得积分10
刚刚
王十七发布了新的文献求助10
刚刚
1秒前
wanci的应助被爽朗的小王同学采纳,获得10
1秒前
瓶子完成签到 ,获得积分10
1秒前
甜美无剑发布了新的文献求助10
1秒前
李健的小迷弟的应助被youyyuy采纳,获得10
2秒前
3秒前
彳亍完成签到,获得积分10
3秒前
4秒前
斯文败类的应助被王新涛采纳,获得10
4秒前
4秒前
2339822272发布了新的文献求助10
4秒前
我是谁的应助被小胖采纳,获得30
5秒前
充电宝的应助被云晓采纳,获得10
6秒前
充电宝的应助被阿楠采纳,获得10
6秒前
yyt完成签到 ,获得积分10
6秒前
爆米花的应助被dan1029采纳,获得10
6秒前
Hello的应助被dan1029采纳,获得10
6秒前
李爱国的应助被dan1029采纳,获得10
6秒前
CodeCraft的应助被dan1029采纳,获得10
6秒前
6秒前
小蘑菇的应助被dan1029采纳,获得10
6秒前
6秒前
万能图书馆的应助被dan1029采纳,获得10
6秒前
Akim的应助被dan1029采纳,获得10
7秒前
sss完成签到 ,获得积分10
7秒前
李健的应助被dan1029采纳,获得10
7秒前
斯文雁易完成签到,获得积分10
7秒前
爆米花的应助被dan1029采纳,获得10
7秒前
04d的应助被dan1029采纳,获得10
7秒前
7秒前
啊吼吼完成签到,获得积分10
7秒前
7秒前
专注的半雪完成签到,获得积分10
7秒前
烟花的应助被CWJ采纳,获得10
7秒前
7秒前
黑米完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287